FDAFDA · Food and drugs·Recall number D-0428-2024
Tri-Lo-Sprintec (norgestimate and ethinyl estradiol) tablets USP - triphasic regimen, packaged in carton containing 3 Blister Cards, 28 Tablets Each, Rx only, Teva Pharmaceuticals USA, INC, North Wales, PA 19454, NDC 0093-2140-62
Published April 3, 2024 · Recall initiated: March 7, 2024
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- TRI-LO-SPRINTEC
- Manufacturer
- Teva Pharmaceuticals USA, Inc
- Distributor
- USA nationwide.
- Lot
- Lot # 100039678, Exp 04/31/2024; 100038111, 100042277, Exp 07/31/2024
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.